3/19
06:09 am
opt
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024 [Yahoo! Finance]
Neutral
Report
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024 [Yahoo! Finance]
3/19
06:00 am
opt
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
Neutral
Report
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
3/5
05:16 pm
opt
Opthea to Participate in the Leerink Partners Global Biopharma Conference [Yahoo! Finance]
Medium
Report
Opthea to Participate in the Leerink Partners Global Biopharma Conference [Yahoo! Finance]
3/5
05:08 pm
opt
Opthea to Participate in the Leerink Partners Global Biopharma Conference
Medium
Report
Opthea to Participate in the Leerink Partners Global Biopharma Conference
2/28
05:59 pm
opt
Opthea Reports Half-Year Financial Results and Business Updates [Yahoo! Finance]
Low
Report
Opthea Reports Half-Year Financial Results and Business Updates [Yahoo! Finance]
2/28
05:55 pm
opt
Opthea Reports Half-Year Financial Results and Business Updates
Low
Report
Opthea Reports Half-Year Financial Results and Business Updates
2/19
06:33 pm
opt
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor [Yahoo! Finance]
Medium
Report
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor [Yahoo! Finance]
2/19
06:25 pm
opt
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
Medium
Report
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
2/14
07:12 am
opt
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept [Yahoo! Finance]
Low
Report
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept [Yahoo! Finance]
2/14
07:00 am
opt
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
Low
Report
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
2/1
06:15 am
opt
Opthea Strengthens Team with Key Clinical and Regulatory Hires [Yahoo! Finance]
Low
Report
Opthea Strengthens Team with Key Clinical and Regulatory Hires [Yahoo! Finance]
2/1
06:00 am
opt
Opthea Strengthens Team with Key Clinical and Regulatory Hires
Low
Report
Opthea Strengthens Team with Key Clinical and Regulatory Hires
1/31
01:09 pm
opt
Wet-Age Related Macular Degeneration Market to Observe Stupendous Growth by 2032, Predicts DelveInsight | Key Players - AbbVie, Opthea, AffaMed Therapeutics, EyeBiotech, Novartis, Hoffmann-La Roche, Kyowa Kirin, Skyline Therapeutics [Yahoo! Finance]
Low
Report
Wet-Age Related Macular Degeneration Market to Observe Stupendous Growth by 2032, Predicts DelveInsight | Key Players - AbbVie, Opthea, AffaMed Therapeutics, EyeBiotech, Novartis, Hoffmann-La Roche, Kyowa Kirin, Skyline Therapeutics [Yahoo! Finance]
1/10
04:52 pm
opt
The Netty Awards Announces Their Latest 'Winners to Watch' List [Yahoo! Finance]
Low
Report
The Netty Awards Announces Their Latest 'Winners to Watch' List [Yahoo! Finance]